SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-16-008937
Filing Date
2016-12-08
Accepted
2016-12-08 17:02:01
Documents
63
Period of Report
2016-10-31

Document Format Files

Seq Description Document Type Size
1 c86732_10q.htm 10-Q 557850
2 c86732_ex31-1.htm EX-31.1 9225
3 c86732_ex31-2.htm EX-31.2 9219
4 c86732_ex32-1.htm EX-32.1 3340
5 c86732_ex32-2.htm EX-32.2 3356
  Complete submission text file 0000930413-16-008937.txt   3679660

Data Files

Seq Description Document Type Size
6 enz-20161031.xml EX-101.INS 690078
7 enz-20161031.xsd EX-101.SCH 51825
8 enz-20161031_cal.xml EX-101.CAL 42632
9 enz-20161031_def.xml EX-101.DEF 210152
10 enz-20161031_lab.xml EX-101.LAB 324069
11 enz-20161031_pre.xml EX-101.PRE 220657
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 162042074
SIC: 8071 Services-Medical Laboratories